Skip to main content

Table 1 Patient characteristics

From: Increased serum neurofilament light chain concentration indicates poor outcome in Guillain-Barré syndrome

Patient no.

Sex

Age

sNfL (pg/ml)

CSF dissoc.

CSF protein

Albumin index

NCS

Diagnostic certainty

Treatment

Ganglioside

1

m

53

88.9

No

34.1

4.2

Primary demyelinating

2

IVIg

Neg

2

f

80

246.4

Yes

119.8

23.2

Primary demyelinating

1

IVIg

Neg

3

m

48

238.0

Yes

54.8

12.6

Primary demyelinating

2

IVIg, PE, ICU

Neg

4

m

65

65.0

No

44.3

5.5

Primary demyelinating

2

IVIg

Neg

5

m

77

57.8

No

43.4

5.8

Primary demyelinating

2

IVIg, PE, ICU

Neg

6

f

59

45.0

Yes

68.8

12.6

Primary demyelinating

1

IVIg

Neg

7

f

74

135.3

Yes

175.6

35.0

Primary demyelinating

1

IVIg, ICU

Neg

8

f

45

71.7

No

36.0

5.2

Primary demyelinating

2

IVIg

Neg

9

m

52

77.3

Yes

57.2

12.9

Primary demyelinating

1

IVIg

Neg

10

m

65

17.9

Yes

53.2

8.9

Primary demyelinating

1

IVIg

Neg

11

m

37

383.0

Yes

67.5

17.8

Primary demyelinating

1

IVIg, PE

Neg

12

m

20

229.7

Yes

76.7

12.9

Primary demyelinating

1

IVIg, PE, ICU

Neg

13

m

54

204.5

No

47.4

17.3

Primary demyelinating

1

IVIg, PE, ICU

Neg

14

m

70

41.5

No

45.1

5.3

Primary demyelinating

2

IVIg

Neg

15

m

74

249.0

Yes

55.2

15.8

Primary demyelinating

1

IVIg

Neg

16

f

22

499.8

Yes

157.8

34.9

Primary demyelinating

1

IVIg, PE, ICU

Neg

17

m

73

146.6

Yes

70.5

14.0

Primary demyelinating

1

IVIg

Neg

18

w

30

30.7

Yes

16.7

2.3

Primary axonal

2

IVIg

GM1

19

f

78

12.9

No

45.3

6.0

Primary axonal

1

IVIg

Neg

20

m

66

85.5

Yes

102.5

21.0

Primary axonal

1

IVIg

Neg

21

f

66

46.7

No

28.5

4.6

Primary axonal

2

IVIg, PE, ICU

GM1

22

m

30

139.0

No

32.1

4.6

Primary axonal

2

IVIg, PE, ICU

GD1a

23

m

31

17.2

Yes

86.5

14.0

Equivocal

1

IVIg

Neg

24

f

40

82.6

Yes

74.2

13.6

Equivocal

1

IVIg

Neg

25

f

34

18.6

Yes

30.2

4.1

Equivocal

1

IVIg

Neg

26

m

74

210.5

No

46.8

9.7

Equivocal

1

IVIg, ICU

Neg

27

w

59

684.7

Yes

76.4

13.0

Equivocal

1

IVIg, PE, ICU

Neg

  1. Analysed data from this study cohort (n = 27): demographic information, serum neurofilament light chain (sNfL) concentration upon admission, CSF results (albumin-cytological dissociation, total CSF protein count [mg/dl] and albumin index [× 1000]), results from nerve conduction studies (NCS) according to Hadden criteria [4], the level of diagnostic certainty (Brighton criteria [25]), information on the treatment strategy (IVIg intravenous immunoglobulin; PE plasma exchange; ICU transfer to an intensive care unit) and results from anti-ganglioside antibody testing